GMP Compliance: An AHPA Tele-Seminar Series

GMP Compliance: An AHPA Tele-Seminar Series AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods. FWS Restores 5-Year Minimum Age for Exported American Ginseng The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). FWS Restores 5-Year Minimum Age for Exported American Ginseng The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. Enzymotec Receives NDI status for CardiaBeat(TM) Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Multivitamin/ Mineral Supplements Conference Report This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention. Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA). CRN Applauds Senators On AER Bill Introduction CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them. CRN Applauds Senators On AER Bill Introduction CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them. Introduction of AER Bill in U.S. Senate Announced A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days. Introduction of AER Bill in U.S. Senate Announced A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days. Introduction of AER Bill in U.S. Senate Announced A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days. Introduction of AER Bill in U.S. Senate Announced A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. NNFA Statement on Adverse Event Reporting Legislation NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements. FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].” FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].” Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members. Public Comment Sought on Mandatory Folic Acid Fortification The Australia and New Zealand Food Regulation Ministerial Council asked FSANZ to consider developing a food standard for the mandatory fortification of food with folic acid. A draft standard recommending that folic acid be added to flour used for bread making is now available for public comment. Public Comment Sought on Mandatory Folic Acid Fortification The Australia and New Zealand Food Regulation Ministerial Council asked FSANZ to consider developing a food standard for the mandatory fortification of food with folic acid. A draft standard recommending that folic acid be added to flour used for bread making is now available for public comment. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. SLIMALUMA Achieves Self-Affirmed GRAS Status Expert panel affirms product's saftety for use in foods. POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada. POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada. POS Pilot Plant Receives Health Canada Site License for Manufacturing Natural Health Products POS Pilot Plant has received its site license for manufacturing natural health products for sale in Canada. FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement FDA is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON, products that are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, as they are illegal drugs that contain potentially harmful undeclared ingredients. FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement FDA is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON, products that are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, as they are illegal drugs that contain potentially harmful undeclared ingredients. UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” UK's MHRA to Require Label Warning on Black Cohosh The Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. issued a press release today in which it stated that it “is concerned about links between black cohosh (Actaea racemosa; syn: Cimicifuga racemosa) and the risk of liver disorders. MHRA has therefore determined that warnings will be required on labeling of black cohosh products and it “is working with the herbal sector to ensure the public is fully informed about this potential risk.” ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. ORAFTI’s Beneo(TM) Inulin Approved as a Dietary Fiber in Canada has obtained approval for the classification of Beneo(TM) inulin as a dietary fiber for labeling purposes in Canada. Open Call for Nominations to the Expert Advisory Committee (EAC) on Natural Health Products The Natural Health Products Directorate (NHPD) is seeking to fill six positions with the EAC. The closing date for nominations is August 21, 2006. Open Call for Nominations to the Expert Advisory Committee (EAC) on Natural Health Products The Natural Health Products Directorate (NHPD) is seeking to fill six positions with the EAC. The closing date for nominations is August 21, 2006. Open Call for Nominations to the Expert Advisory Committee (EAC) on Natural Health Products The Natural Health Products Directorate (NHPD) is seeking to fill six positions with the EAC. The closing date for nominations is August 21, 2006. EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	*American Herbal Products Association Educational Seminars Present:* GMP Compliance: An AHPA Tele-Seminar Series (Silver Spring, MD, June 28, 2006) -- FDA’s final dietary supplement GMPs have been under development for more than a decade, but it is still anyone's guess when these regulations will finally be published. Even today though, dietary supplement manufacturers are required to comply with the same GMP standards that apply to food producers. And many herbal companies have imposed higher standards on their own facilities to keep up with their customers’ increasing demands for product quality. How does your company’s GMP measure up to current industry standards? Are you ready to comply with FDA’s new rules? AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published. Each tele-seminar will include presentations by a panel of experts with specific knowledge and experience, relevant to the numerous topics included in each seminar. Useful documents will be distributed at each tele-seminar, and a written transcript will follow each event. Even if you already have a good GMP system in place, the AHPA GMP Compliance Tele-Seminar Series can help you identify where you might need to tighten up your procedures. Currently planned tele-seminars include: Introduction to Good Manufacturing Practices For Dietary Supplement Products: Strategies for Compliance - August 3, 2006. Botanical Identity/Herb Quality - September 28, 2006. The Quality Unit - Early November, 2006. Date to Be Announced. If you manufacture an herbal product, you will learn how to evaluate your current GMP system and to prepare for new demands that may soon be included in FDA’s final rule on dietary supplement GMP. Be ready before the FDA knocks at your door – make sure your company is prepared. Register for one or all on AHPA’s website: http://www.ahpa.org/portals/0/pdfs/06_08_AHPA_cGMP.xls Either fax back the form or return by email. The Tele-Seminars 1. Introduction to Good Manufacturing Practice for Dietary Supplement Products: Strategies for Compliance (click for course outline) Date: August 3, 2006 • Time: 1pmET – 3pmET *Objective:* This practical introduction will provide insight into some critical GMP systems that you should have in place. The expert panel will provide a background to the GMP for dietary supplements, FDA authority, DSHEA, the goals of the GMP, and an overview of how compliance and FDA oversight works. It will also offer the basics of how to create the organizational structure for your business, including personnel, documentation, systems, facility and SOP creation. The seminar will also help you anticipate business impacts and costs of compliance. 2. Botanical Identity/Herb Quality (click for course outline) Date: September 28, 2006 • Time: 1pmET – 3pmET *Objective:* The foundations of the herbal products industry rely upon purchasing quality herbs and herbal extracts, qualifying vendors, and confirming herb identification. Ensuring that herbs and herbal products meet all specifications for quality, compliance, and safety is no simple matter. This session will provide both basic and advanced tools for herb identification, preventing adulteration, and quality measurements. 3. The Quality Unit (click for course outline) Date: Early November. Date to be announced • Time: 1pmET – 3pmET *Objective:* This session will address the critical requirement to have an independent quality group within your company, the responsibilities and authority of the quality group, and how to manage quality for product excellence, consumer safety, compliance, company liability, and practical cost considerations. Where: Your telephone or office conference room Cost: $195 per tele-seminar, per listening site for members / $495 per listening site for non-members (no matter how many people are in the room) Registration: register for one or all three with this online form to fax or email back: http://www.ahpa.org/portals/0/pdfs/06_08_AHPA_cGMP.xls Advance registration only; the deadline is one week prior to each event. Once registered, a confirmation email will be sent to you within two days and all supporting resource documents (developed specifically for each tele-seminar) and instructions will be sent by email 48 hours prior to the event. If you have any questions, please contact Devon Powell at dpowell@ahpa.org, or 301-588-1171, x102. Each tele-seminar begins at 1:00 pm ET / 12:00 noon CT / 11:00 am MT / 10:00 am PT and lasts for two hours. The cost of participation per tele-seminar is $195 (AHPA Members) / $495 (non-members) per connection. This includes an unedited transcript and a Certification of Completion, an important addition to cGMP compliance training and personnel files; additional certificates cost $25 each. An audio CD will be available for an additional $25. AHPA’s tele-seminars are a convenient and cost-effective way to explore issues, gain insight and enhance knowledge important to your herbal and dietary supplement business. You will be provided with very useful documents to assist with GMP compliance. The tele-seminars are live telephone conference calls. Please note, the registration fee is charged per phone connection, but as many staff members as you wish may listen in on your speaker phone. ### The American Herbal Products Association (AHPA) represents the core of the botanical trade -- comprised of the finest growers, processors, manufacturers and marketers of herbal products -- AHPA’s mission is to promote the responsible commerce of herbal products. AHPA committees generate self-regulations to ensure the highest level of quality with respect to the way herbs are manufactured, labeled, and sold.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software